Details for New Drug Application (NDA): 209510
✉ Email this page to a colleague
NDA 209510 describes BARHEMSYS, which is a drug marketed by Acacia and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the BARHEMSYS profile page.
The generic ingredient in BARHEMSYS is amisulpride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amisulpride profile page.
The generic ingredient in BARHEMSYS is amisulpride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amisulpride profile page.
Summary for 209510
| Tradename: | BARHEMSYS |
| Applicant: | Acacia |
| Ingredient: | amisulpride |
| Patents: | 5 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 209510
Generic Entry Date for 209510*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY Dosage:
SOLUTION;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for NDA: 209510
| Mechanism of Action | Dopamine D2 Antagonists |
Suppliers and Packaging for NDA: 209510
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BARHEMSYS | amisulpride | SOLUTION;INTRAVENOUS | 209510 | NDA | Acacia Pharma Ltd | 71390-125 | 71390-125-20 | 10 CARTON in 1 PACKAGE (71390-125-20) / 1 VIAL, SINGLE-DOSE in 1 CARTON (71390-125-21) / 2 mL in 1 VIAL, SINGLE-DOSE |
| BARHEMSYS | amisulpride | SOLUTION;INTRAVENOUS | 209510 | NDA | Acacia Pharma Ltd | 71390-125 | 71390-125-50 | 10 CARTON in 1 PACKAGE (71390-125-50) / 1 VIAL, SINGLE-DOSE in 1 CARTON (71390-125-51) / 4 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 5MG/2ML (2.5MG/ML) | ||||
| Approval Date: | Feb 26, 2020 | TE: | RLD: | Yes | |||||
| Regulatory Exclusivity Expiration: | Feb 26, 2025 | ||||||||
| Regulatory Exclusivity Use: | NEW CHEMICAL ENTITY | ||||||||
| Patent: | ⤷ Try a Trial | Patent Expiration: | Mar 10, 2031 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | ⤷ Try a Trial | Patent Expiration: | Feb 9, 2038 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | TREATMENT OF POST-OPERATIVE NAUSEA AND VOMITING | ||||||||
Complete Access Available with Subscription
